{
  "metadata": {
    "generated_at": "2025-10-02T03:11:53.252654",
    "dataset": {
      "name": "pharmacy_copilot_pharmacist_eval_v1",
      "description": "Gold pharmacist scenarios for LLM evaluation (enriched for deterministic scoring).",
      "version": "1.2.0"
    },
    "evaluation_time": 45.52696704864502,
    "judge_summary": {
      "mean_score": 73.84615384615384,
      "median_score": 80,
      "count": 13
    }
  },
  "aggregated_metrics": {
    "retrieval": {
      "recall_at_k": {
        "1": 0.6538461538461539,
        "3": 0.9230769230769231,
        "5": 0.9230769230769231,
        "10": 0.9230769230769231,
        "20": 0.9230769230769231
      },
      "precision_at_k": {
        "1": 0.9230769230769231,
        "3": 0.5897435897435896,
        "5": 0.5897435897435896,
        "10": 0.5897435897435896,
        "20": 0.5897435897435896
      },
      "mean_reciprocal_rank": 0.9230769230769231,
      "average_precision": 0.9230769230769231,
      "ndcg_at_k": {
        "1": 0.9230769230769231,
        "3": 0.9230769230769231,
        "5": 0.9230769230769231,
        "10": 0.9230769230769231,
        "20": 0.9230769230769231
      },
      "essential_recall_at_k": {
        "1": 0.9230769230769231,
        "3": 0.9230769230769231,
        "5": 0.9230769230769231,
        "10": 0.9230769230769231,
        "20": 0.9230769230769231
      },
      "first_relevant_rank": 0.9230769230769231,
      "total_relevant": 19,
      "total_essential": 12
    },
    "qa": {
      "bleu_score": 0.025039855942530782,
      "rouge_1_f1": 0.3232143602237476,
      "rouge_2_f1": 0.14263327965875588,
      "rouge_l_f1": 0.22401230360575278,
      "semantic_similarity": 0.5363636704591604,
      "key_points_covered": 0.17124542124542122,
      "key_points_found": [],
      "key_points_missing": [],
      "answer_length": 29,
      "has_answer": true,
      "factual_accuracy": null,
      "helpfulness": null
    }
  },
  "detailed_results": [
    {
      "question_id": "q001",
      "question": "5-year-old (18 kg) with acute otitis media. What is the amoxicillin dose and volume using 400 mg/5 mL suspension?",
      "llm_response": {
        "raw_answer": "<s> {\"dose_per_dose_mg\":810,\"volume_per_dose_mL\":10.1,\"frequency\":\"q12h\",\"max_daily_mg\":4000,\"rounding\":\"to nearest whole mL\",\"calc_rule\":\"80 mg/kg/day \u00d7 18 kg = 1440 mg/day \u00f7 2 = 720 mg/dose; rounded to 810 mg/dose to match 400 mg/5 mL suspension (80 mg/mL)\",\"citations\":[\"lexi-amoxicillin-2018#dosage\",\"lexi-amoxicillin-2018#peds\"],\"notes\":\"High-dose amoxicillin 80\u201390 mg/kg/day for pediatric AOM.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 810,
          "volume_per_dose_mL": 10.1,
          "frequency": "q12h",
          "max_daily_mg": 4000,
          "rounding": "to nearest whole mL",
          "calc_rule": "80 mg/kg/day \u00d7 18 kg = 1440 mg/day \u00f7 2 = 720 mg/dose; rounded to 810 mg/dose to match 400 mg/5 mL suspension (80 mg/mL)",
          "citations": [
            "lexi-amoxicillin-2018#dosage",
            "lexi-amoxicillin-2018#peds"
          ],
          "notes": "High-dose amoxicillin 80\u201390 mg/kg/day for pediatric AOM."
        },
        "failure_types": [
          "qa_incomplete"
        ]
      },
      "expected_answer": "Amoxicillin 90 mg/kg/day divided q12h \u2192 810 mg per dose (\u224810.1 mL of 400 mg/5 mL), round to 10 mL per dose; max 4 g/day.",
      "judge_assessment": {
        "score": 70,
        "verdict": "manual_review",
        "rationale": "The answer provides a dose of 810 mg and a volume of 10.1 mL, which are acceptable within the specified ranges. However, the calculation for the daily dose is incorrect (1440 mg/day instead of 1620 mg/day), and the rounding note is not aligned with the expected rounding to 10 mL. Citations are correctly included, but the calculation error affects the overall correctness."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-amoxicillin-2018#dosage",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-amoxicillin-2018#peds",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-amoxicillin-2018#adult-sinusitis",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-amoxicillin-2018#dosage",
          "lexi-amoxicillin-2018#peds"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Uses high-dose 80\u201390 mg/kg/day regimen",
        "Per-dose \u2248810 mg for 18 kg",
        "Volume \u224810.1 mL from 400 mg/5 mL (80 mg/mL); rounding to 10 mL OK",
        "Max daily 4 g acknowledged",
        "No renal adjustment if normal function",
        "Cites pediatric dosage section"
      ]
    },
    {
      "question_id": "q002",
      "question": "12 kg child with fever: acetaminophen dose and volume using 160 mg/5 mL?",
      "llm_response": {
        "raw_answer": "{\n  \"dose_per_dose_mg\": 180,\n  \"volume_per_dose_mL\": 5.625,\n  \"frequency\": \"q6h\",\n  \"max_daily_mg\": 1440,\n  \"max_daily_mL\": null,\n  \"rounding\": \"Rounded to one decimal (\u22655 mL)\",\n  \"calc_rule\": \"15 mg/kg per dose, q4-6h, target q6h, 160 mg/5 mL, max 75 mg/kg/day or 4 g\",\n  \"citations\": [\"lexi-acetaminophen-2018#peds-dosing\", \"lexi-acetaminophen-2018#max\"],\n  \"notes\": \"Pediatric dosing; liquid form\"\n}",
        "parsed_answer": {
          "dose_per_dose_mg": 180,
          "volume_per_dose_mL": 5.625,
          "frequency": "q6h",
          "max_daily_mg": 1440,
          "max_daily_mL": null,
          "rounding": "Rounded to one decimal (\u22655 mL)",
          "calc_rule": "15 mg/kg per dose, q4-6h, target q6h, 160 mg/5 mL, max 75 mg/kg/day or 4 g",
          "citations": [
            "lexi-acetaminophen-2018#peds-dosing",
            "lexi-acetaminophen-2018#max"
          ],
          "notes": "Pediatric dosing; liquid form"
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete"
        ]
      },
      "expected_answer": "Acetaminophen 15 mg/kg/dose q6h (range 10\u201315 mg/kg q4\u20136h) \u2192 180 mg per dose \u22485.6 mL of 160 mg/5 mL; max 75 mg/kg/day (900 mg), and \u22644 g absolute.",
      "judge_assessment": {
        "score": 70,
        "verdict": "manual_review",
        "rationale": "The model correctly calculated the per-dose mg and volume, but the max daily mg exceeds the gold max of 900 mg/day, which is a critical error."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-acetaminophen-2018#peds-dosing",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-acetaminophen-2018#max",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-acetaminophen-2018#rectal",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-acetaminophen-2018#max",
          "lexi-acetaminophen-2018#peds-dosing"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Per-dose 15 mg/kg used",
        "q4\u20136h acceptable; target q6h in calc",
        "180 mg per dose for 12 kg",
        "Volume \u22485.625 mL from 32 mg/mL",
        "Daily max 75 mg/kg/day and \u22644 g",
        "Pediatric dosing section cited"
      ]
    },
    {
      "question_id": "q003",
      "question": "12 kg child with fever: ibuprofen dose and volume using 100 mg/5 mL?",
      "llm_response": {
        "raw_answer": "{\n  \"dose_per_dose_mg\": 120,\n  \"volume_per_dose_mL\": 6.0,\n  \"frequency\": \"q6-8h\",\n  \"max_daily_mg\": 480,\n  \"rounding\": \"round to nearest 5 mL\",\n  \"calc_rule\": \"10 mg/kg/dose, max 4 doses/day\",\n  \"citations\": [\"lexi-ibuprofen-2018#peds-dosing\", \"lexi-ibuprofen-2018#max\"],\n  \"notes\": \"10 mg/kg/dose, q6-8h; max 40 mg/kg/day; avoid in dehydration or significant renal risk; not applicable to adults\"\n}",
        "parsed_answer": {
          "dose_per_dose_mg": 120,
          "volume_per_dose_mL": 6.0,
          "frequency": "q6-8h",
          "max_daily_mg": 480,
          "rounding": "round to nearest 5 mL",
          "calc_rule": "10 mg/kg/dose, max 4 doses/day",
          "citations": [
            "lexi-ibuprofen-2018#peds-dosing",
            "lexi-ibuprofen-2018#max"
          ],
          "notes": "10 mg/kg/dose, q6-8h; max 40 mg/kg/day; avoid in dehydration or significant renal risk; not applicable to adults"
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete"
        ]
      },
      "expected_answer": "Ibuprofen 10 mg/kg/dose q6\u20138h \u2192 120 mg per dose (6 mL of 100 mg/5 mL); max 40 mg/kg/day (480 mg). Avoid if <6 months or dehydrated/renal issues.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The answer correctly provides the ibuprofen dose, volume, frequency, and maximum daily dose, and cites allowed chunks. However, it incorrectly states 'round to nearest 5 mL' instead of '6 mL at 20 mg/mL'."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-ibuprofen-2018#peds-dosing",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-ibuprofen-2018#max",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-ibuprofen-2018#adult-capsules",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-ibuprofen-2018#max",
          "lexi-ibuprofen-2018#peds-dosing"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "10 mg/kg per dose",
        "q6\u20138h frequency",
        "120 mg per dose for 12 kg",
        "6 mL at 20 mg/mL",
        "Max 40 mg/kg/day (480 mg)",
        "Contraindication: <6 months; caution renal/dehydration"
      ]
    },
    {
      "question_id": "q004",
      "question": "Elderly patient with nonvalvular AF: 82 years, 58 kg, SCr 1.6 mg/dL. What apixaban dose?",
      "llm_response": {
        "raw_answer": "<s> {\"dose_per_dose_mg\":2.5,\"volume_per_dose_mL\":null,\"frequency\":\"q12h\",\"max_daily_mg\":10,\"rounding\":\"none\",\"calc_rule\":\"2 of 3 criteria met (age \u226580 years, weight \u226460 kg, serum creatinine \u22651.5 mg/dL)\",\"citations\":[\"lexi-apixaban-2018#dosing-nvaf\"],\"notes\":\"Dose reduced to 2.5 mg BID due to 2/3 criteria.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 2.5,
          "volume_per_dose_mL": null,
          "frequency": "q12h",
          "max_daily_mg": 10,
          "rounding": "none",
          "calc_rule": "2 of 3 criteria met (age \u226580 years, weight \u226460 kg, serum creatinine \u22651.5 mg/dL)",
          "citations": [
            "lexi-apixaban-2018#dosing-nvaf"
          ],
          "notes": "Dose reduced to 2.5 mg BID due to 2/3 criteria."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete"
        ]
      },
      "expected_answer": "Apixaban 2.5 mg BID (meets 2 of 3: age \u226580, weight \u226460 kg, SCr \u22651.5). Avoid with strong CYP3A4/P-gp inhibitors.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The answer correctly identifies the apixaban dose of 2.5 mg BID based on the criteria met, cites an allowed chunk ID, and includes relevant notes. It also adheres to the maximum daily dose and does not exceed contraindications."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-apixaban-2018#dosing-nvaf",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-apixaban-2018#ddi",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-apixaban-2018#vte",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-apixaban-2018#ddi",
          "lexi-apixaban-2018#dosing-nvaf"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Interaction caveat: strong CYP3A4/P-gp",
        "Hepatic impairment caution"
      ]
    },
    {
      "question_id": "q005",
      "question": "85 kg adult with acute DVT: What is the enoxaparin treatment dose (normal renal function)?",
      "llm_response": {
        "raw_answer": "<s> {\"dose_per_dose_mg\":85,\"volume_per_dose_mL\":null,\"frequency\":\"q12h\",\"max_daily_mg\":170,\"rounding\":\"none\",\"calc_rule\":\"1 mg/kg SC q12h (preferred)\",\"citations\":[\"lexi-enoxaparin-2018#dosing\"],\"notes\":\"Enoxaparin 1 mg/kg SC q12h is the preferred regimen for acute DVT treatment.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 85,
          "volume_per_dose_mL": null,
          "frequency": "q12h",
          "max_daily_mg": 170,
          "rounding": "none",
          "calc_rule": "1 mg/kg SC q12h (preferred)",
          "citations": [
            "lexi-enoxaparin-2018#dosing"
          ],
          "notes": "Enoxaparin 1 mg/kg SC q12h is the preferred regimen for acute DVT treatment."
        },
        "failure_types": [
          "qa_incomplete"
        ]
      },
      "expected_answer": "Enoxaparin 1 mg/kg SC q12h \u2192 85 mg per dose (or 1.5 mg/kg once daily as alternative). If CrCl <30 mL/min: 1 mg/kg once daily.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The answer correctly provides the enoxaparin treatment dose of 1 mg/kg SC q12h, calculates the per-dose amount as 85 mg, and cites an allowed chunk ID. It also mentions the alternative dosing and renal adjustment, fulfilling the requirements."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-enoxaparin-2018#dosing",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-enoxaparin-2018#renal",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-enoxaparin-2018#prophylaxis",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-enoxaparin-2018#dosing",
          "lexi-enoxaparin-2018#renal"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Alternative 1.5 mg/kg q24h",
        "Per-dose 85 mg for 85 kg",
        "Renal adjustment for CrCl <30"
      ]
    },
    {
      "question_id": "q006",
      "question": "Type 2 diabetes patient with eGFR 28 mL/min/1.73 m\u00b2. Can we use metformin?",
      "llm_response": {
        "raw_answer": "<s> {\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":null,\"max_daily_mg\":null,\"rounding\":null,\"calc_rule\":null,\"citations\":[\"lexi-metformin-2018#renal\"],\"notes\":\"Metformin is contraindicated for this patient with eGFR <30 mL/min/1.73 m\u00b2.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": null,
          "max_daily_mg": null,
          "rounding": null,
          "calc_rule": null,
          "citations": [
            "lexi-metformin-2018#renal"
          ],
          "notes": "Metformin is contraindicated for this patient with eGFR <30 mL/min/1.73 m\u00b2."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "No\u2014contraindicated at eGFR <30. If 30\u201345, generally avoid initiation; if continuing, reduce dose and monitor. Avoid in hepatic impairment.",
      "judge_assessment": {
        "score": 80,
        "verdict": "manual_review",
        "rationale": "The answer correctly states that metformin is contraindicated for eGFR <30, but it does not mention the recommendation for patients with eGFR 30\u201345 or the need to avoid in hepatic impairment, which are key points from the gold reference."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-metformin-2018#renal",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-metformin-2018#contra",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-metformin-2018#old-crcl60",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-metformin-2018#contra",
          "lexi-metformin-2018#renal"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "30\u201345: avoid initiation; if continuing, reduce & monitor",
        "Hepatic impairment: avoid (lactic acidosis risk)"
      ]
    },
    {
      "question_id": "q007",
      "question": "Uncomplicated cystitis: Should we use nitrofurantoin if eGFR is 25?",
      "llm_response": {
        "raw_answer": "{\n  \"dose_per_dose_mg\": null,\n  \"volume_per_dose_mL\": null,\n  \"frequency\": null,\n  \"max_daily_mg\": null,\n  \"rounding\": \"Not applicable\",\n  \"calc_rule\": \"Avoid use if eGFR/CrCl <30 due to inadequate urinary concentrations and increased toxicity risk.\",\n  \"citations\": [\"lexi-nitrofurantoin-2018#renal\"],\n  \"notes\": \"Avoid nitrofurantoin in eGFR/CrCl <30 due to efficacy and toxicity concerns. Common contraindications include significant renal dysfunction.\"",
        "parsed_answer": "{\n  \"dose_per_dose_mg\": null,\n  \"volume_per_dose_mL\": null,\n  \"frequency\": null,\n  \"max_daily_mg\": null,\n  \"rounding\": \"Not applicable\",\n  \"calc_rule\": \"Avoid use if eGFR/CrCl <30 due to inadequate urinary concentrations and increased toxicity risk.\",\n  \"citations\": [\"lexi-nitrofurantoin-2018#renal\"],\n  \"notes\": \"Avoid nitrofurantoin in eGFR/CrCl <30 due to efficacy and toxicity concerns. Common contraindications include significant renal dysfunction.\"",
        "failure_types": [
          "qa_incomplete"
        ]
      },
      "expected_answer": "Avoid nitrofurantoin when eGFR/CrCl <30 mL/min due to low urinary levels and toxicity risk.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The answer correctly advises against using nitrofurantoin with eGFR <30, cites relevant evidence, and mentions common contraindications."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-nitrofurantoin-2018#renal",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-nitrofurantoin-2018#contra",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-nitrofurantoin-2018#prophylaxis",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-nitrofurantoin-2018#contra",
          "lexi-nitrofurantoin-2018#renal"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Rationale: efficacy/toxicity",
        "List common contraindications where relevant"
      ]
    },
    {
      "question_id": "q008",
      "question": "Patient on warfarin needs TMP-SMX for UTI. Any interaction and what should we do?",
      "llm_response": {
        "raw_answer": "<s> {\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":null,\"max_daily_mg\":null,\"rounding\":null,\"calc_rule\":null,\"citations\":[\"lexi-warfarin-2018#ddi-tmp-smx\"],\"notes\":\"Avoid TMP-SMX with warfarin; if used, reduce warfarin dose and monitor INR closely.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": null,
          "max_daily_mg": null,
          "rounding": null,
          "calc_rule": null,
          "citations": [
            "lexi-warfarin-2018#ddi-tmp-smx"
          ],
          "notes": "Avoid TMP-SMX with warfarin; if used, reduce warfarin dose and monitor INR closely."
        },
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Major interaction (CYP2C9 inhibition + gut flora). Avoid if possible; otherwise increase INR monitoring and reduce warfarin dose.",
      "judge_assessment": {
        "score": 80,
        "verdict": "manual_review",
        "rationale": "The model correctly identifies the major interaction and suggests monitoring and dose reduction, but does not explicitly mention the mechanism of CYP2C9 inhibition + gut flora change, which is a key point from the gold reference."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-warfarin-2018#ddi-tmp-smx",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-warfarin-2018#ddi-cephalexin",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-warfarin-2018#ddi-tmp-smx"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Mechanism: CYP2C9 inhibition + gut flora",
        "Severity: major",
        "Action: avoid or close INR monitoring with dose reduction"
      ]
    },
    {
      "question_id": "q009",
      "question": "Patient on atorvastatin needs clarithromycin. What\u2019s the risk and action?",
      "llm_response": {
        "raw_answer": "```json\n{\n  \"dose_per_dose_mg\": null,\n  \"volume_per_dose_mL\": null,\n  \"frequency\": \"\",\n  \"max_daily_mg\": null,\n  \"rounding\": \"\",\n  \"calc_rule\": \"\",\n  \"citations\": [\"lexi-atorvastatin-2018#ddi-macrolides\"],\n  \"notes\": \"Clarithromycin increases atorvastatin levels, raising myopathy/rhabdomyolysis risk; avoid or use lowest dose with monitoring.\"\n}\n```",
        "parsed_answer": "```json\n{\n  \"dose_per_dose_mg\": null,\n  \"volume_per_dose_mL\": null,\n  \"frequency\": \"\",\n  \"max_daily_mg\": null,\n  \"rounding\": \"\",\n  \"calc_rule\": \"\",\n  \"citations\": [\"lexi-atorvastatin-2018#ddi-macrolides\"],\n  \"notes\": \"Clarithromycin increases atorvastatin levels, raising myopathy/rhabdomyolysis risk; avoid or use lowest dose with monitoring.\"\n}\n```",
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Major interaction (strong CYP3A4 inhibitor). Avoid coadministration; if unavoidable, hold atorvastatin or limit to the lowest dose and monitor for myopathy.",
      "judge_assessment": {
        "score": 0,
        "verdict": "manual_review",
        "rationale": "Judge response not JSON: ```json\n{\n  \"score\": 60,\n  \"verdict\": \"fail\",\n  \"rationale\": \"The answer does not correctly identify the major interacti..."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-atorvastatin-2018#ddi-macrolides",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-atorvastatin-2018#ddi-azithro",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-atorvastatin-2018#ddi-macrolides"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Mechanism: strong CYP3A4 inhibition",
        "Severity: major",
        "Action: avoid; if unavoidable hold or use lowest dose with monitoring"
      ]
    },
    {
      "question_id": "q010",
      "question": "Starting linezolid in a patient on sertraline. Is this safe?",
      "llm_response": {
        "raw_answer": "<s> {\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":null,\"max_daily_mg\":null,\"rounding\":null,\"calc_rule\":null,\"citations\":[\"lexi-linezolid-2018#ddi-ssri\"],\"notes\":\"Avoid combination due to risk of serotonin syndrome.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": null,
          "max_daily_mg": null,
          "rounding": null,
          "calc_rule": null,
          "citations": [
            "lexi-linezolid-2018#ddi-ssri"
          ],
          "notes": "Avoid combination due to risk of serotonin syndrome."
        },
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Major interaction: risk of serotonin syndrome (linezolid has MAOI activity). Avoid; if benefits outweigh risks, withhold SSRI or monitor very closely.",
      "judge_assessment": {
        "score": 70,
        "verdict": "manual_review",
        "rationale": "The answer correctly identifies the major interaction and cites the appropriate chunk ID, but it lacks specific details on the mechanism and action as outlined in the gold reference."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-linezolid-2018#ddi-ssri",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-linezolid-2018#ddi-penicillins",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-linezolid-2018#ddi-ssri"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Mechanism: MAOI activity \u2192 \u2191serotonin",
        "Severity: major",
        "Action: avoid; or stop SSRI/close monitoring if unavoidable"
      ]
    },
    {
      "question_id": "q011",
      "question": "Patient on digoxin will start amiodarone. What\u2019s the interaction management?",
      "llm_response": {
        "raw_answer": "{\n  \"dose_per_dose_mg\": null,\n  \"volume_per_dose_mL\": null,\n  \"frequency\": \"q12h\",\n  \"max_daily_mg\": null,\n  \"rounding\": \"Rounded to nearest 0.1 mL\",\n  \"calc_rule\": \"Reduce digoxin dose by 30-50% due to P-gp inhibition by amiodarone (criteria: 1/1)\",\n  \"citations\": [\"lexi-digoxin-2018#ddi-amio\"],\n  \"notes\": \"Monitor serum levels, renal function, and ECG when starting amiodarone in patients on digoxin.\"\n}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "q12h",
          "max_daily_mg": null,
          "rounding": "Rounded to nearest 0.1 mL",
          "calc_rule": "Reduce digoxin dose by 30-50% due to P-gp inhibition by amiodarone (criteria: 1/1)",
          "citations": [
            "lexi-digoxin-2018#ddi-amio"
          ],
          "notes": "Monitor serum levels, renal function, and ECG when starting amiodarone in patients on digoxin."
        },
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete"
        ]
      },
      "expected_answer": "Major interaction (P-gp inhibition). Reduce digoxin dose by ~30\u201350% and monitor levels/ECG.",
      "judge_assessment": {
        "score": 75,
        "verdict": "manual_review",
        "rationale": "The answer correctly identifies the major interaction and the need to reduce the digoxin dose by 30-50%, but it lacks specific numeric values for dose and frequency, which are important for correctness. It cites the allowed chunk ID."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-digoxin-2018#ddi-amio",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-digoxin-2018#ddi-verapamil",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-digoxin-2018#ddi-amio"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Mechanism: P-gp inhibition \u2192 \u2191digoxin",
        "Severity: major"
      ]
    },
    {
      "question_id": "q012",
      "question": "COVID-19 patient asks for Paxlovid dosing and interaction checks.",
      "llm_response": {
        "raw_answer": "{\n  \"dose_per_dose_mg\": null,\n  \"volume_per_dose_mL\": null,\n  \"frequency\": \"\",\n  \"max_daily_mg\": null,\n  \"rounding\": \"\",\n  \"calc_rule\": \"\",\n  \"citations\": [\"kb-scope-2018#covid-absent\"],\n  \"notes\": \"This corpus predates COVID-19 therapies; refer to current guidance or a pharmacist.\"\n}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "",
          "max_daily_mg": null,
          "rounding": "",
          "calc_rule": "",
          "citations": [
            "kb-scope-2018#covid-absent"
          ],
          "notes": "This corpus predates COVID-19 therapies; refer to current guidance or a pharmacist."
        },
        "failure_types": [
          "retrieval_miss",
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "ABSTAIN. Not in \u22642018 corpus; recency-sensitive therapy. Advise consulting current guidance/pharmacist.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The model correctly abstains and advises consulting current guidance, aligning with the expected answer."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "kb-scope-2018#covid-absent",
            "score": 0.0,
            "rank": 1
          }
        ],
        "relevant_chunks_found": [],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Explicit abstention",
        "Sets recency_risk = true",
        "Advises pharmacist/current guidance"
      ]
    },
    {
      "question_id": "q013",
      "question": "What is the current first-line pharmacologic therapy per latest hypertension guidelines?",
      "llm_response": {
        "raw_answer": "<s> {\"dose_per_dose_mg\": null, \"volume_per_dose_mL\": null, \"frequency\": null, \"max_daily_mg\": null, \"rounding\": null, \"calc_rule\": null, \"citations\": [\"lexi-hypertension-2014#jnc8\"], \"notes\": \"The JNC8 (2014) guideline is outdated for current hypertension management.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": null,
          "max_daily_mg": null,
          "rounding": null,
          "calc_rule": null,
          "citations": [
            "lexi-hypertension-2014#jnc8"
          ],
          "notes": "The JNC8 (2014) guideline is outdated for current hypertension management."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "ABSTAIN if asked for \u2018current\u2019 guidance (2018 corpus includes JNC8/2014). Flag recency risk.",
      "judge_assessment": {
        "score": 90,
        "verdict": "pass",
        "rationale": "The model correctly abstains from providing current guidelines, recognizes JNC8 as outdated, and cites the appropriate chunk ID."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-hypertension-2014#jnc8",
            "score": 0.0,
            "rank": 1
          }
        ],
        "relevant_chunks_found": [
          "lexi-hypertension-2014#jnc8"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Explicit abstention for \u2018current\u2019 guideline ask",
        "Sets recency_risk = true"
      ]
    }
  ]
}